Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-08-28 Sale | 2024-08-30 4:15 pm | Y-mAbs Therapeutics Inc. | YMAB | Lund-Hansen Torben SVP & CHIEF TECHNICAL OFFICER | 50,000 | $15.37 | $768,500 | 181,262 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-08-28 Exercise | 2024-08-30 4:15 pm | N/A 2026-05-20 | Y-mAbs Therapeutics Inc. | YMAB | Lund-Hansen Torben SVP & CHIEF TECHNICAL OFFICER | 50,000 | $0 | 181,262 (Direct) | View |
| 2024-08-28 Exercise | 2024-08-30 4:15 pm | N/A N/A | Y-mAbs Therapeutics Inc. | YMAB | Lund-Hansen Torben SVP & CHIEF TECHNICAL OFFICER | 50,000 | $4.38 | 181,262 (Direct) | View |
| 2024-01-18 Option Award | 2024-01-22 5:54 pm | N/A 2034-01-18 | Y-mAbs Therapeutics Inc. | YMAB | Lund-Hansen Torben SVP & CHIEF TECHNICAL OFFICER | 53,500 | $0 | 116,962 (Direct) | View |
| 2023-01-26 Option Award | 2023-01-30 4:34 pm | N/A 2033-01-26 | Y-mAbs Therapeutics Inc. | YMAB | Lund-Hansen Torben SVP & CHIEF TECHNICAL OFFICER | 32,000 | $0 | 32,000 (Direct) | View |
| 2023-01-17 Option Award | 2023-01-19 4:44 pm | N/A 2033-01-17 | Y-mAbs Therapeutics Inc. | YMAB | Lund-Hansen Torben SVP & CHIEF TECHNICAL OFFICER | 53,500 | $0 | 99,162 (Direct) | View |
| 2022-04-26 Option Award | 2022-04-28 6:21 pm | N/A 2032-04-26 | Y-mAbs Therapeutics Inc. | YMAB | Lund-Hansen Torben SVP & CTO | 20,000 | $0 | 20,000 (Direct) | View |
| 2021-12-14 Option Award | 2021-12-16 6:05 pm | N/A 2031-12-14 | Y-mAbs Therapeutics Inc. | YMAB | Lund-Hansen Torben SVP & CTO | 32,000 | $0 | 32,000 (Direct) | View |
| 2020-12-15 Option Award | 2020-12-16 6:05 pm | N/A 2030-12-15 | Y-mAbs Therapeutics Inc. | YMAB | Lund-Hansen Torben SVP & CTO | 20,000 | $0 | 20,000 (Direct) | View |
| 2019-12-10 Option Award | 2019-12-11 5:04 pm | N/A 2029-12-10 | Y-mAbs Therapeutics Inc. | YMAB | Lund-Hansen Torben Sr. VP & CTO | 20,000 | $0 | 20,000 (Direct) | View |